Arkolith/Insider Trading/ORKA/Form 4

Goncalves Joana

Chief Medical OfficerOruka Therapeutics, Inc. (ORKA) · full profile →Form 4 · filed May 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$433K
Net Open-Market Flow
-$433K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2026Option exercise(M)4K$6.84$24K37K
May 15, 2026Option exercise(M)4K$7.80$27K40K
May 15, 2026Sell(S)5K$61.56$295K36K
May 15, 2026Sell(S)2K$62.42$131K33K
May 15, 2026Sell(S)100$63.52$6K33K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 15, 2026Option exercise(M)4K—$0208K
May 15, 2026Option exercise(M)4K—$0179K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000907654-26-000039) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML